D.A. Davidson & CO. Raises Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG)

D.A. Davidson & CO. raised its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 0.9% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 13,198 shares of the medical equipment provider’s stock after buying an additional 115 shares during the quarter. D.A. Davidson & CO.’s holdings in Intuitive Surgical were worth $6,889,000 at the end of the most recent quarter.

Several other large investors also recently added to or reduced their stakes in the stock. Bennett Selby Investments LP grew its holdings in Intuitive Surgical by 3.9% in the 4th quarter. Bennett Selby Investments LP now owns 449 shares of the medical equipment provider’s stock valued at $234,000 after buying an additional 17 shares in the last quarter. LVW Advisors LLC grew its holdings in shares of Intuitive Surgical by 1.3% during the 4th quarter. LVW Advisors LLC now owns 1,448 shares of the medical equipment provider’s stock worth $756,000 after purchasing an additional 19 shares during the period. Wesbanco Bank Inc. grew its holdings in shares of Intuitive Surgical by 1.6% during the 4th quarter. Wesbanco Bank Inc. now owns 1,216 shares of the medical equipment provider’s stock worth $635,000 after purchasing an additional 19 shares during the period. FSM Wealth Advisors LLC grew its holdings in shares of Intuitive Surgical by 3.7% during the 4th quarter. FSM Wealth Advisors LLC now owns 526 shares of the medical equipment provider’s stock worth $275,000 after purchasing an additional 19 shares during the period. Finally, Journey Strategic Wealth LLC grew its holdings in shares of Intuitive Surgical by 1.9% during the 4th quarter. Journey Strategic Wealth LLC now owns 1,039 shares of the medical equipment provider’s stock worth $542,000 after purchasing an additional 19 shares during the period. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of equities analysts have recently weighed in on ISRG shares. Stifel Nicolaus increased their price target on Intuitive Surgical from $525.00 to $610.00 and gave the stock a “buy” rating in a report on Thursday, December 5th. Royal Bank of Canada increased their price target on Intuitive Surgical from $611.00 to $641.00 in a report on Monday, January 27th. Bernstein Bank increased their price target on Intuitive Surgical from $655.00 to $700.00 and gave the stock an “overweight” rating in a report on Monday, January 27th. JPMorgan Chase & Co. raised their target price on Intuitive Surgical from $575.00 to $675.00 and gave the company an “overweight” rating in a report on Friday, January 24th. Finally, Evercore ISI raised their target price on Intuitive Surgical from $490.00 to $530.00 in a report on Monday, January 27th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and sixteen have given a buy rating to the company’s stock. Based on data from MarketBeat, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and a consensus target price of $613.10.

Intuitive Surgical Stock Performance

Shares of NASDAQ ISRG opened at $608.48 on Thursday. Intuitive Surgical, Inc. has a fifty-two week low of $364.17 and a fifty-two week high of $616.00. The firm has a market capitalization of $216.73 billion, a PE ratio of 94.93, a price-to-earnings-growth ratio of 5.74 and a beta of 1.39. The stock’s 50-day simple moving average is $563.17 and its 200-day simple moving average is $522.88.

Insider Transactions at Intuitive Surgical

In related news, EVP Robert Desantis sold 376 shares of the firm’s stock in a transaction that occurred on Friday, November 29th. The stock was sold at an average price of $539.00, for a total transaction of $202,664.00. Following the transaction, the executive vice president now owns 5,506 shares in the company, valued at $2,967,734. This trade represents a 6.39 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, CFO Jamie Samath sold 108 shares of the firm’s stock in a transaction that occurred on Tuesday, November 26th. The stock was sold at an average price of $542.06, for a total value of $58,542.48. Following the transaction, the chief financial officer now owns 8,757 shares in the company, valued at $4,746,819.42. This represents a 1.22 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 6,348 shares of company stock valued at $3,587,582. Corporate insiders own 0.80% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.